News
A list of Press Releases and Upcoming Meetings can be found at the pages below:
Will "metabesity' supercede 'diabesity' in metabolic syndrome marketing? Nutraingredients USA
As waistlines around the globe continue to swell, researchers and marketers struggle to find a rhetorical way to get their hands around the problem. First there was obesity, which became “diabesity,” adding diabetes to the mix. The latest entrant in the coin-a-disease-trend-word sweepstakes is “metabesity.”
Duchenne Muscular Dystrophy - Advocates, Patients Rally to Support Sarepta Early Drug Approval Push
"The eteplirsen trial included a very small number of patients but the counterpoint is that these are patients with a genetic defect that is being targeted precisely by the mechanism of action of this drug," said Dr. Alex Fleming, a former FDA drug reviewer who now runs Kinexum, a healthcare consulting firm.
